Not selling CSL. Not buying either.
Plenty happening in the landscape of global healthcare/biotechs. Good to have a holistic view within a resilient sector as a whole. There's been new developments in terms of advancement for treatments for chronic and hereditary conditions. CSL is a spoke in a big wheel. Remove the blinkers. Set yourself free.
just like the pro resources poster who speaks of protecting capital, it should be obvious to all that price makers have a distinct advantage over price takers.
That's how it's been through every market cycle.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$239.11 |
Change
0.010(0.00%) |
Mkt cap ! $115.9B | |||
| Open | High | Low | Value | Volume |
| $238.55 | $241.28 | $237.66 | $85.33M | 356.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 204 | $239.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $239.11 | 8 | 1 |
View Market Depth
| Last trade - 15.44pm 17/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |